Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk among Patients with Advanced CKD

CONCLUSIONS: For patients with advanced CKD, continuing fenofibrate may provide a protective effect on CV outcomes equal to that of statins, and it may further delay the need for permanent dialysis. The combination of fenofibrate and high intensity statins may have additional benefits.PMID:33677489 | DOI:10.1210/clinem/dgab137

Source: The Journal of Clinical Endocrinology and Metabolism - March 7, 2021 Category: Endocrinology Authors: Chieh-Li Yen Pei-Chun Fan Ming-Shyan Lin Cheng-Chia Lee Kun-Hua Tu Chao-Yu Chen Ching-Chung Hsiao Hsiang-Hao Hsu Ya-Chun Tian Chih-Hsiang Chang Source Type: research